IM Cannabis

About

Funding history · 15 rounds · $75.1M total

Acquisitions · 8

Offices

Q&A

What is IM Cannabis's primary focus?

IM Cannabis is an international cannabis company that focuses on providing premium cannabis products to medical patients in Israel and Germany.

When was IM Cannabis founded?

IM Cannabis was founded in 2008.

How many employees does IM Cannabis have?

IM Cannabis has 11-50 employees.

What was IM Cannabis's most recent funding event?

In September 2026, IM Cannabis completed a Public Offering, raising $1,310,000 from accredited investors.

What was the total amount raised by IM Cannabis?

IM Cannabis has raised a total of $72,981,660.

What was IM Cannabis's most recent debt financing round?

In January 2026, IM Cannabis secured $2,171,660 in Debt Financing from an arm's length third party.

Which company did IM Cannabis acquire in March 2026?

In March 2026, IM Cannabis acquired Blackaxe Technologies.

Who is the CEO of IM Cannabis?

Oren Shuster is the Chief Executive Officer of IM Cannabis.

What is the current status of IM Cannabis?

IM Cannabis is a public company.

Team · 13

Oren Shuster

Founder · Chief Executive Officer

Asi Levi

Chief Financial Officer

Richard Balla

CEO and Director, German Operations – Adjupharm GmbH

Yael Harrosh

Chief Legal & Operations Officer

Shai Shemesh

CFO

Michael Ruscetta

Co-Head North America & CEO of Trichome Financial Corp.

Howard Steinberg

Co-Head North America & CEO of TJAC

Oz Adler

Chairman of the Board

Moti Marcus

Director

Asaf Yitzhaik

Director

Einat Zakariya

Director

Eli Zamir

Director

Shmulik Arbel

Director

Sectors & technology

Tags